ArticleJournal of applied clinical medical physics2025
Commissioning of a gantry-mounted synchrocyclotron for preclinical FLASH studies utilizing spread-out Bragg peaks.
Article in Journal of applied clinical medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Pulse-by-pulse ultra-high resolution scintillation imaging of proton FLASH beams produced by a gantry-mounted synchrocyclotron.Physics in medicine and biology · 2025Article
- Commissioning of a gantry-mounted synchrocyclotron for preclinical FLASH studies utilizing spread-out Bragg peaks.Journal of applied clinical medical physics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundPreclinical studies demonstrate the benefits of ultra-high dose-rate (FLASH) radiation, reducing normal tissue toxicity while maintaining tumoricidal effects. Proton FLASH (pFLASH) studies typically use transmission beams, missing the normal tissue-sparing advantage of the spread-out Bragg peak (SOBP). PURPOSE: This study aims to propose and implement a series of modifications to enable a clinical Mevion S250i gantry-mounted synchrocyclotron to deliver pFLASH within the SOBP of the proton beam.
methodsA clinical synchrocyclotron was modified to enable FLASH proton beam delivery using the Mevion FLASH accessory kit, a commercially available tool that allows for the delivery of a single spot SOBP at FLASH dose rates. To ensure accurate beam monitoring, a Faraday cup was utilized to measure the integral charge per delivery at different dose rates and calibrate the FLASH transmission ion chamber (FLASHTic), which is integrated in the FLASH accessory mount attached to the nozzle of the gantry. The FLASHTic was specifically designed to prevent saturation at the dose rates associated with FLASH. To generate the desired single spot SOBP, boron carbide absorbers, a range modulating hole filter, and an 11-mm-diameter circle brass aperture were employed on the FLASH nozzle mount.
resultsThe results indicate that the FLASHTic measurements demonstrated a strong correlation with the Faraday cup post calibration, suggesting that the FLASHTic can be effectively utilized for both monitoring and terminating the proton beam. The 80%-80% width of the SOBP was 2.01 cm. The peak dose rate at the SOBP proximal peak reached 105.03 Gy/s, with an average of 96.18 Gy/s over five days. Transitioning between FLASH and clinical mode required less than one hour without affecting the clinical beam.
conclusionsThe commissioning of a 230 MeV proton synchrocyclotron for SOBP FLASH delivery was achieved, providing a platform for preclinical small animal studies on pFLASH effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.